Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 4Breast Neoplasms 3Pain 2Lung Neoplasms 2Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Hemorrhage 1Nerve Block 1Musculoskeletal Diseases 1Mouth Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Hypotension 1Head and Neck Neoplasms 1Goiter 1Chronic Pain 1Carcinoma, Renal Cell 1Bowen's Disease 1Agnosia 1Acute Upper Gastrointestinal Bleeding 1Acute Pain 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × Epinephrine × Clear all
NCT04032119 2025-05-04

RCT of Gastric ESD With or Without Epineprhine Added Solution

Chinese University of Hong Kong

Phase 3 Completed
800 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡